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The mitochondrial fission machinery, comprising a dynamin-related GTPase, DRP-1, is crucial for 
the regulation of mitochondrial membrane dynamics. Recent reports suggest that the tubular 
architecture of the endoplasmic reticulum (ER) marks the constriction sites on the mitochondria to 
facilitate DRP-1-mediated mitochondrial fission. However, the role of several ER shaping proteins 
that maintain the elaborate network of tubes and sheets in mitochondrial constriction and fission is 
not yet known. In this report, we demonstrate that modulation of the expression levels of key ER 
shaping proteins, namely Reticulon1 (RTN-1), Reticulon 4 (RTN-4), Lunapark-1 (LNP-1) and 
CLIMP-63, markedly decreased the extent of mitochondrial fission mediated by BH3 mimetics, 
despite no detectable changes in DRP-1 recruitment to the mitochondria. Furthermore, modulation of 
ER shaping proteins significantly decreased other hallmarks of apoptosis, such as mitochondrial 
outer membrane permeabilization, caspase activation and phosphatidylserine externalization, and 
functioned independently of mitochondrial cristae remodeling, thus demonstrating a requirement of 











Mitochondria are highly dynamic organelles, which depend on the activities of 
several membrane-bound fusion and fission GTPases, such as mitofusins, OPA1 and DRP-1, 
to maintain their structure [1]. Defects in mitochondrial fusion and fission events have been 
implicated in a range of pathophysiological conditions including poor brain development, 
optic atrophy, cardiomyopathy and neurodegenerative diseases [2,3]. While the fusion 
GTPases, such as mitofusins and OPA1, reside on mitochondrial membranes, the fission 
GTPase, DRP-1 is normally translocated from the cytosol to the outer mitochondrial 
membrane (OMM) to facilitate mitochondrial fission [4]. The recruitment of DRP-1 to 
mitochondria has been shown to occur following the marking of mitochondrial constriction 
sites by the endoplasmic reticulum (ER) [5]. Moreover, several other proteins, such as INF2, 
Spire1C, actin, Septin 2, Dynamin-2, have been implicated in these events to aid in 
mitochondrial fission [6-11]. 
 Maintenance of mitochondrial structure is critical for several processes, ranging from 
metabolism and bioenergetics to intracellular signalling and apoptosis. Most cancer 
chemotherapeutic agents induce cancer cell death by perturbing mitochondria and activating 
the intrinsic apoptotic pathway. Several cancers express high levels of the anti-apoptotic 
BCL-2 family of proteins, such as BCL-2, BCL-XL and MCL-1, which can be inhibited by a 
new class of highly specific and potent drugs called BH3 mimetics [12,13]. Some of these 
inhibitors, such as ABT-199 (BCL-2 specific), A-1331852 (BCL-XL specific) and A-
1210477 and S63845 (MCL-1 specific) are already approved for use in patients or in clinical 
trials to treat different malignancies [14-18]. BH3 mimetics perturb mitochondrial integrity 
by causing mitochondrial outer membrane permeabilization (MOMP) and a concomitant 
release of cytochrome c, thereby resulting in caspase activation and apoptosis [13,19]. Our 
recent findings have revealed a role for DRP-1 in BH3 mimetic-mediated mitochondrial 
fission and apoptosis [20].  
In this report, we demonstrate that DRP-1 is required for BH3 mimetic-mediated 
induction of MOMP and apoptosis. Furthermore, we characterize a critical role for several 
ER shaping proteins in the execution of BH3 mimetic-mediated mitochondrial fission, 
MOMP and apoptosis, thus revealing new molecular insights into the mechanisms underlying 
ER membrane dynamics and cancer cell death. 
 
 
Results and Discussion 
 
DRP-1 is critical for MOMP during BH3 mimetic-mediated apoptosis  
 Our earlier findings demonstrated a requirement for DRP-1 in BH3 mimetic-mediated 
apoptosis in several cell lines derived from solid tumors [20]. Since most solid tumors depend 
on both BCL-XL and MCL-1 for survival, neutralization of both these proteins (using a 
combination of specific BH3 mimetics) is required to induce apoptosis in these cancers. In 
agreement, exposure of H1299 cells to a combination of A-1331852 and A-1210477, to 
inhibit BCL-XL and MCL-1, respectively, resulted in a near-complete release of 
mitochondrial cytochrome c (Fig.1A). This was markedly reduced following a genetic 
knockdown (siRNA) of DRP-1 or a dominant negative DRP-1 mutant (K38A), thus placing 
DRP-1 upstream of MOMP (Fig. 1A). Surprisingly, the observed retention of cytochrome c 
occurred in mitochondria that were visibly swollen (Fig. 1A). Support for this was provided 
by the ultrastructural alterations of mitochondria in cells exposed to BH3 mimetics, which 
included breaks in the OMM (denoted by the yellow arrowhead), mitochondrial matrix 
swelling and a concomitant loss of cristae (Fig. 1B). Downregulation of DRP-1 resulted in 
elongated mitochondria in the control cells and exposure of these cells to BH3 mimetics 
resulted in visibly swollen mitochondria with intact cristae in the absence of OMM breaks 
(Fig. 1B).  
 
DRP-1 acts downstream of cristae remodelling during BH3 mimetic-mediated apoptosis 
 MOMP is generally accompanied by the release of mitochondrial cytochrome c from 
the inner membrane space to the cytosol, as a consequence of mitochondrial cristae 
remodelling [21]. Exposure to BH3 mimetics caused a loss of the high molecular weight 
isoforms of OPA1, characteristic of mitochondrial cristae remodelling [22,23], which was 
accompanied by an almost complete release of mitochondrial cytochrome c into the cytosol 
(Fig. 1C). Downregulation of DRP-1 markedly diminished the release of mitochondrial 
cytochrome c but failed to prevent OPA1 proteolysis, induced by the combination of BH3 
mimetics (Fig. 1C). Downregulation of DRP-1 not only prevented the mitochondrial fission 
following the loss of fusion in OPA1 siRNA-transfected cells but also inhibited the complete 
release of cytochrome c, following exposure to the BH3 mimetics in the OPA1 
downregulated cells (Fig. 1D).  In an analogous manner, downregulation of Drp-1 inhibited 
the extensive apoptosis, assessed by phosphatidylserine (PS) externalization even following 
downregulation of OPA1 (Fig. 1E). Thus these data indicate that DRP-1 plays a role 
downstream of cristae remodelling and also upstream of cytochrome c release.  
 
ER shaping proteins regulate BH3 mimetic-mediated mitochondrial fission    
Since the ER tubules have been shown to mark the constriction sites on the 
mitochondria to facilitate DRP-1-mediated fission [5], we speculated whether modulating the 
expression levels of ER shaping proteins could alter mitochondrial membrane dynamics and 
function. To test this hypothesis, we genetically silenced the expression levels of some of key 
ER shaping proteins, namely Reticulon1 (RTN-1), Reticulon4 (RTN-4), Lunapark-1 (LNP-1) 
and CLIMP-63 in H1299 cells. Of these, RTN-1 and RTN-4 contribute to the curvature and 
maintenance of ER tubules, whereas CLMP-63 helps to maintain ER sheets [24,25]. LNP-1 is 
localized to the three-way junctions in the ER and contributes to ER network formation 
[26,27]. In cells transfected with siRNAs targeting these ER shaping proteins, we wished to 
assess changes in mitochondrial structure, following inducers of mitochondrial fission, such 
as A-1210477 (MCL-1 inhibitor) and CCCP (mitochondrial uncoupler). Downregulation of 
DRP-1 prevented both A-1210477- and CCCP-mediated mitochondrial fission, whereas 
downregulation of the different ER shaping proteins markedly inhibited A-1210477- but not 
CCCP-mediated mitochondrial fission (Figs. 2 A-C). This may be due to the different 
mechanisms by which A-1210477 and CCCP induce mitochondrial fission, with CCCP 
inducing mitochondrial depolarization and Parkin-dependent mitophagy [28]. How MCL-1 
regulates mitochondrial membrane dynamics is largely unknown [29-33]. In H1299 cells, A-
1210477 neither induced mitochondrial depolarization nor mitophagy, despite causing 
marked mitochondrial fission [20]. Furthermore, downregulation of DRP-1 but not ER 
shaping proteins prevented the loss of fusion, following OPA1 siRNA (Figs. 3 A and B). 
Taken together, these results suggested that ER shaping proteins, similar to DRP-1, regulate 
BH3 mimetic-mediated mitochondrial fission but unlike DRP-1, ER shaping proteins are 
dispensable for mitochondrial fission events induced by CCCP and OPA1 downregulation. 
 
ER shaping proteins do not affect DRP-1 recruitment to mitochondria 
 Next, we wished to assess whether the ER shaping proteins regulated mitochondrial 
fission by facilitating DRP-1 translocation and recruitment to the mitochondrial constriction 
sites. Surprisingly, downregulation of the ER shaping proteins did not affect DRP-1 
recruitment to mitochondrial membranes (Fig. 4). Exposure of control cells to A-1210477 
resulted in extensive mitochondrial fission and in these cells DRP-1 was detected proximal to 
the fissed mitochondrial filaments (Fig. 4). Downregulation of the ER shaping proteins 
markedly inhibited A-1210477-mediated mitochondrial fission (Figs. 2B and 4), despite 
DRP-1 being extensively associated with the filamentous mitochondria (Fig. 4). These results 
implied that recruitment and association of DRP-1 alone to the mitochondrial membrane was 
insufficient to induce mitochondrial fission and efficient fission required the involvement of 
ER shaping proteins. However, the absence of ER shaping proteins may alter the 
phosphorylation status and/or the resident time of DRP1 in the mitochondrial membrane. 
 
ER shaping proteins prevent BH3 mimetic-mediated MOMP and apoptosis. 
Since the downregulation of ER shaping proteins antagonized A-1210477-mediated 
mitochondrial fission similar to that of DRP-1 siRNA (Figs. 2 and 4), we wished to 
investigate whether silencing the expression of ER shaping proteins could also prevent BH3 
mimetic-mediated MOMP and apoptosis. Indeed, downregulation of several ER shaping 
proteins, such as RTN-1, RTN-4 and CLIMP-63 but not LNP-1, prevented BH3 mimetic-
mediated MOMP, characterized by the release of mitochondrial cytochrome c (Fig. 5A and 
B). Since the reticulons and CLIMP-63 maintain ER tubules and sheets along with LNP-1, 
which forms the three-way junction to maintain the interconnected ER network, the inability 
of LNP-1 downregulation to prevent BH3 mimetic-mediated MOMP was surprising, and in 
stark contrast to its potential to prevent BH3 mimetic-mediated mitochondrial fission (Figs. 2 
and 5). How or why LNP-1 uncouples BH3 mimetic-mediated mitochondrial fission and 
MOMP needs further characterization.  
 Nevertheless, since DRP-1 facilitated BH3 mimetic-mediated apoptosis downstream 
of mitochondrial cristae remodeling (Fig. 1E), we wondered whether ER shaping proteins 
also regulated apoptosis downstream and/or independent of OPA1 proteolysis. 
Downregulation of ER shaping proteins, unlike DRP-1 siRNA, resulted in a near-complete 
release of cytochrome c, in cells transfected with OPA1 siRNA (Fig. 5C), suggesting that the 
ER shaping proteins, in contrast to DRP-1, regulated mitochondrial dynamics upstream of 
OPA1 proteolysis.  This is consistent with the mitochondrial structural changes observed 
following BH3 mimetics in the different siRNA transfected cells (Fig. 5A). While 
downregulation of DRP-1 resulted in significant mitochondrial swelling following BH3 
mimetics, none of the siRNAs targeting the ER shaping proteins resulted in similar 
mitochondrial swelling (Fig. 5A), thus supporting the notion that ER shaping proteins, unlike 
DRP-1, regulated mitochondrial dynamics upstream of IMM swelling. Finally, silencing the 
expression of most of the ER shaping proteins, except LNP-1 prevented, to varying extents, 
other hallmarks of apoptosis, such as PS externalization (Fig. 5D) and caspase activation, as 
assessed by the cleavage of the apical caspae-9 in the intrinsic pathway of apoptosis as well 
as the effector caspases-3 and -7 (Fig. 5E), following exposure to BH3 mimetics. Taken 
together, our results demonstrate that BH3 mimetics induced apoptosis in a DRP-1-dependent 
manner, in which the ER membranes marked the constriction sites on the mitochondria, 
which in turn facilitated mitochondrial cristae remodeling (OPA1 proteolysis), inner 
mitochondrial membrane swelling, OMM breaks, cytochrome c release, caspase activation 
and PS externalization, thus highlighting a crucial role for the integrity of the mitochondrial 
fission machinery and ER membranes in the efficient execution of BH3 mimetic-mediated 
apoptosis. As BH3 mimetics are currently entering the clinic due to their exquisite specificity 
and potency to induce apoptosis by antagonizing the anti-apoptotic BCL-2 family members, 
knowledge of the interplay between the ER and mitochondria dynamics can lead to more 






Materials and Methods 
 
Cell culture 
H1299 cells purchased from ATCC (Middlesex, UK) and authenticated by short tandem 
repeat (STR) profiling were cultured in RPMI 1640 medium supplemented with 10 % fetal 
calf serum (FCS) from Life Technologies, Inc, (Paisley, UK) and maintained at 37°C in a 
humidified atmosphere of 5% CO2.  
Reagents  
BH3 mimetics, A-1331852 and A-1210477 were kindly provided by AbbVie Inc (IL, USA). 
CCCP was obtained from Selleck Chemicals Co. (Houston, TX, USA). Antibodies against 
HSP60, Cytochrome c, OPA1 and DRP-1 from BD Biosciences (San Jose, CA, USA), RTN-
1, RTN-4, HSP70 from Abcam (Cambridge, UK), CLIMP-63 from Enzo Lifesciences 
(Exeter, UK), LNP-1 from Sigma, cleaved PARP, cleaved caspase 9, caspase-3 and caspase-7 
from Cell Signaling Technologies (Danvers, MA, USA) and GAPDH from SantaCruz 
Biotechnologies (Santa Cruz, CA, USA) were used. All other reagents, unless mentioned 
otherwise, were from Sigma-Aldrich Co. (St. Louis, MO, USA). 
Transfections  
For RNA interference, cells were transfected with 10 nM of siRNAs against DRP-1 
(SI04274235), RTN-1 (SI04178545), RTN-4 (s32767), CLIMP-63 (SI00347242), LNP-1 
(SI00460355) and OPA1 (SI03019429) purchased from either Life Technologies or Qiagen 
Ltd. (Manchester, UK), using Interferin (Polyplus Transfection Inc, NY), according to the 
manufacturer's protocol and processed 72 h after transfection. For transient overexpression, 
cells were transfected with GFP-DRP-1-DN (provided by Dr. E. Bampton, University of 
Leicester, UK) using Lipofectamine LTX reagent (Thermo Fisher Scientific, Loughborough, 
UK) and incubated for 48 h, according to the manufacturer’s instructions. 
Microscopy 
For immunofluorescent staining, cells grown on coverslips were fixed with 4 % (w/v) 
paraformaldehyde, permeabilized with 0.5 % (v/v) Triton X-100 in PBS, followed by 
incubations with primary antibodies, the appropriate fluorophore-conjugated secondary 
antibodies, mounted on glass slides and imaged using a 3i Marianas spinning disk confocal 
microscope, fitted with a Plan-Apochromat 63x/1.4NA Oil Objective, M27 and a Hamamatsu 
ORCA-Flash4.0 v2 sCMOS Camera (all from Intelligent Imaging Innovations, GmbH, 
Germany). For transmission electron microscopy, cells were prepared based on the Deerinck 
and Ellisman SBF SEM protocol [34]. Electron micrographs were recorded using a 
MegaViewIII CCD camera and AnalySIS software (EMSIS GmbH, Germany) in a FEI 
Tecnai G2 Spirit BioTWIN electron microscope. Acquired images were processed using 
ImageJ software (NIH, Bethesda, MD). 
Flow cytometry 
Cells were collected, washed with PBS and resuspended in 500 µL of Annexin binding buffer 
containing 150 mM NaCl, 1 mM MgCl2, 5 mM KCl, 2 mM CaCl2, 10 mM HEPES, pH 7.4 
and Annexin-FITC and incubated for 8 min. This was followed by the addition of 2.5 µg of 
PI and further incubated for 2 min and apoptosis was assessed by measuring the extent of 
phosphatidylserine externalization, using an Attune NxT flow cytometer (ThermoFisher 
Scientific, Paisley, UK).  
Cytochrome c release assay  
Roughly a million cells were collected, washed twice with PBS at 4 °C and the pellets 
resuspended in 100 µL of lysis buffer containing 250 mM sucrose, 5 mM MgCl2, 10 mM 
KCl, 1 mM EDTA, 1 mM EGTA, 20 mM HEPES, 0.01 % digitonin, pH 7.4 at 4°C and 
incubated on ice for 5 min. The cells were then centrifuged at 14,000 g for 3 min at 4 °C and 
the supernatant collected. The pellet was resuspended in lysis buffer without digitonin and 
centrifuged again at 14,000 g for 3 min at 4°C. The supernatant was pooled with the 
previously collected supernatant to form the cytosolic fraction. The remaining pellet was 
resuspended in lysis buffer without digitonin and sonicated to form the mitochondrial 
fraction. Western blotting was then carried out in corresponding fractions to assess the extent 
of cytochrome c released from the mitochondria to the cytosol.  
Western blotting 
Western blotting was carried out according to standard protocols. Briefly, 50 µg of total 
protein lysate was subjected to SDS-PAGE electrophoresis. Subsequently proteins were 
transferred to nitrocellulose membrane and protein bands visualized with ECL reagents (GE 
Healthcare).   
Statistical Analysis 
For time-course studies, a two-way ANOVA was performed and other studies were analyzed 
for statistical significance with one-way ANOVA and the asterisks depicted correspond to the 
following p values:  * p ≤ 0.05, ** p ≤ 0.005 and *** p ≤ 0.001. 
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Figure 1. DRP-1 regulates BH3 mimetic-induced mitochondrial fission and apoptosis 
downstream of mitochondrial cristae remodelling.  
A H1299 cells, transfected with DRP-1 siRNA or DRP-1 K38A for 72 h, were exposed 
to Z-VAD.fmk (30 µM) for 0.5 h, followed by a combination of BH3 mimetics, A-1331852 
(100 nM) and A-1210477 (10 µM) for 4 h and the extent of cytochrome c released from 
mitochondria was quantified by counting at least 100 cells from three independent 
experiments. The confocal images in the right panel indicate the inhibitory role of DRP-1 
downregulation in BH3 mimetic-mediated release of mitochondrial cytochrome c. The boxed 
regions in the images are enlarged to show mitochondrial structural changes in the indicated 
cells.  
B Electron microscopy of H1299 cells, transfected with DRP-1 siRNA for 72 h in the 
presence or absence of the indicated BH3 mimetics for 2 h. Breaks in the outer mitochondrial 
membrane are indicated by the yellow arrowhead. Scale bars = 10 nm.  
C Same as (A), but the extent of cytochrome c release as well as OPA-1 processing and 
the silencing efficiency of DRP-1 siRNA were analyzed by western blotting.  
D H1299 cells were transfected with the indicated siRNAs for 72 h and treated as (A) 
and the extent of cytochrome c release assessed and quantified.  
E Same as (D) but the cells were exposed to BH3 mimetics in the absence of Z-
VAD.fmk and the extent of apoptosis assessed by PS externalization.  
Data information: The data in all graphs are presented as Mean ± SEM. ***P⩽0.001 (one- 
way ANOVA). All Scale bars, unless indicated otherwise correspond to 10 µm. 
 
Figure 2. ER shaping proteins are required for A-1210477- but not CCCP-mediated 
mitochondrial fission.  
A H1299 cells transfected with the indicated siRNA for 72 h were exposed to DMSO, 
CCCP (20 µM, 2 h) or A-1210477 (10 µM, 4 h) and the extent of mitochondrial fission 
assessed by HSP60 staining. The boxed regions in the images are enlarged to show 
mitochondrial structural changes in the indicated cells.  
B The extent of fission in these cells was then quantified by counting at least 100 cells 
from three independent experiments.  
C Western blots showing the silencing efficiency of the different siRNAs. 
Data information: The data in the graph are presented as Mean ± SEM. ***P⩽0.001 (one- 
way ANOVA). Scale bars correspond to 10 µm. 
 
Figure 3. Silencing of DRP-1 but not ER shaping proteins rescues mitochondrial 
structural changes due to loss of fusion.  
A H1299 cells were transfected with either control, DRP-1, RTN-1, RTN-4, LNP-1 or 
CLIMP-63 siRNA alone or in combination with OPA-1 siRNA and assessed for 
mitochondrial integrity by HSP60 staining. The boxed regions in the images are enlarged to 
show mitochondrial structural changes in the indicated cells. Scale bars = 10 µm.  
B The extent of fission in these cells was then quantified by counting at least 100 cells 
from three independent experiments.  
Data information: The data in the graph are presented as Mean ± SEM. *p ≤ 0.05 and 
***P⩽0.001 (one- way ANOVA). Scale bars correspond to 10 µm. 
 
Figure 4. DRP-1 localizes to the mitochondrial fission sites independently of ER shaping 
proteins. H1299 cells, transfected with the indicated siRNA for 72 h, were exposed to 
DMSO or A-1210477 (10 µM, 4 h) and immunostained for DRP-1 and HSP70. The boxed 
regions in the images are enlarged to show DRP-1 localization to the mitochondria in the 
indicated cells. Data information: Scale bars =10 µm. 
 
Figure 5. ER shaping proteins antagonize BH3 mimetic-mediated mitochondrial outer 
membrane permeabilization and apoptosis upstream of cristae remodelling.  
A H1299 cells were transfected with the indicated siRNAs for 72 h and exposed to Z-
VAD.fmk (30 µM) for 0.5 h, followed by a combination of BH3 mimetics, A-1331852 (100 
nM) and A-1210477 (10 µM) for 4 h and the extent of cytochrome c released from 
mitochondria was monitored. 
B At least 100 cells from (A) were quantified for the extent of cytochrome c release 
from three independent experiments.  
C Same as (A) but the experiments were performed in cells which were also transfected 
with OPA1 siRNA for 72 h.  
D and E Same as (A) but the cells were exposed to BH3 mimetics in the absence of Z-
VAD.fmk and the extent of apoptosis assessed by (D) PS externalization and (E) western 
blotting for the activation of caspases and the cleavage of poly(ADP-ribose) polymerase 
(PARP).  
Data information: The data in the graph are presented as Mean ± SEM. *p ≤ 0.05 and 
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